AXL expression analysis in 87 mesothelioma patients showed that AXL expression was stronger in mesothelioma (MESO) than in most cancer types, including ovarian cancers, NSCLC, colon adenocarcinoma, and so on (Figure 1A and Figure S1A), confirming our previous immunoblotting observations [11]. This evidence concerns the gene AXL and colon adenocarcinoma.